These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10690322)

  • 1. NO in the cardiovascular system.
    Shah AM; Vallance P; Harrison D
    Cardiovasc Res; 1999 Aug; 43(3):507-8. PubMed ID: 10690322
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of vascular nitric oxide in physiological and pathological conditions.
    Marín J; Rodríguez-Martínez MA
    Pharmacol Ther; 1997 Aug; 75(2):111-34. PubMed ID: 9428001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide signaling in the cardiovascular system--physiology and pathology.
    Malinski T
    Postepy Hig Med Dosw; 1999; 53(2):205-7. PubMed ID: 10355286
    [No Abstract]   [Full Text] [Related]  

  • 4. Nitric oxide and the cardiovascular system.
    Welch G; Loscalzo J
    J Card Surg; 1994 May; 9(3):361-71. PubMed ID: 8054733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin and nitric oxide.
    Gryglewski RJ
    Acta Haematol Pol; 1994; 25(2 Suppl 2):75-81. PubMed ID: 7998478
    [No Abstract]   [Full Text] [Related]  

  • 6. Nitric oxide and cardiovascular and renal effects.
    Raij L
    Osteoarthritis Cartilage; 2008; 16 Suppl 2():S21-6. PubMed ID: 18794014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway.
    Vallance P; Leiper J
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1023-30. PubMed ID: 15105281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide.
    Moncada S
    J Hypertens Suppl; 1994 Dec; 12(10):S35-9. PubMed ID: 7539493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caveolae and caveolins in the cardiovascular system.
    Gratton JP; Bernatchez P; Sessa WC
    Circ Res; 2004 Jun; 94(11):1408-17. PubMed ID: 15192036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NO Signaling in the Cardiovascular System and Exercise.
    Fernandes T; Gomes-Gatto CV; Pereira NP; Alayafi YR; das Neves VJ; Oliveira EM
    Adv Exp Med Biol; 2017; 1000():211-245. PubMed ID: 29098624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric Oxide Donors and the Treatment of Cardiovascular Disease. Proceedings of a symposium. New Orleans, Louisiana, November 15, 1992.
    J Cardiovasc Pharmacol; 1993; 22 Suppl 7():S1-58. PubMed ID: 7504761
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nitric oxide--basal biochemistry and physiological aspects].
    Kirkebøen KA; Andreassen AK; Kvernmo HD; Strand OA
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4056-60. PubMed ID: 10613097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide, free radicals and cell signalling in cardiovascular disease.
    Darley-Usmar VM; McAndrew J; Patel R; Moellering D; Lincoln TM; Jo H; Cornwell T; Digerness S; White CR
    Biochem Soc Trans; 1997 Aug; 25(3):925-9. PubMed ID: 9388574
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice.
    Liu VW; Huang PL
    Cardiovasc Res; 2008 Jan; 77(1):19-29. PubMed ID: 17658499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity.
    Ii M; Nishimura H; Iwakura A; Wecker A; Eaton E; Asahara T; Losordo DW
    Circulation; 2005 Mar; 111(9):1114-20. PubMed ID: 15723985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the role of nitric oxide and its clinical applications.
    Levine AB; Punihaole D; Levine TB
    Cardiology; 2012; 122(1):55-68. PubMed ID: 22722323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemistry and pathobiochemistry of signal transduction in cardiovascular cells].
    Walter U; Halbrügge M; Nolte C; Eigenthaler M; Lohman SM
    Verh Dtsch Ges Inn Med; 1991; 97():582-8. PubMed ID: 1808949
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitric oxide--friend and foe.
    Springall DR
    J Pathol; 1995 Feb; 175(2):165-6. PubMed ID: 7738710
    [No Abstract]   [Full Text] [Related]  

  • 19. Endothelial nitric oxide synthase plays an obligatory role in the late phase of ischemic preconditioning by activating the protein kinase C epsilon p44/42 mitogen-activated protein kinase pSer-signal transducers and activators of transcription1/3 pathway.
    Xuan YT; Guo Y; Zhu Y; Wang OL; Rokosh G; Bolli R
    Circulation; 2007 Jul; 116(5):535-44. PubMed ID: 17606840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preconditioning versus postconditioning: mechanisms and therapeutic potentials.
    Crisostomo PR; Wairiuko GM; Wang M; Tsai BM; Morrell ED; Meldrum DR
    J Am Coll Surg; 2006 May; 202(5):797-812. PubMed ID: 16648020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.